comparemela.com

Latest Breaking News On - Pcsk9 - Page 1 : comparemela.com

Vaxxinity's Heart Health Innovation to Reduce LDL Cholesterol Levels

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it demonstrated that VXX-401 lowers LDL cholesterol, supporting its potential for treating hypercholesterolemia. The VXX-401, a synthetic peptide vaccine, aims to provide a safe and effective solution against heart disease by targeting PCSK9, the company said in a statement. The studies were published in the Journal of […]

Daniella-parra
Nasdaq
Vaxxinity-inc
Journal-of-lipid-research
Lipid-research
Vldl-cholesterol
Heart-disease
Vaxxinity
Synthetic-peptide-vaccine
Effective-solution
Journal-of-lipid-research
Pcsk9

Progress In Treating High Cholesterol: Clinical Trial Interim Results

People with genetically high levels of “bad” LDL cholesterol could replace daily pills or intermittent injections with a single infusion.

High-density-lipoprotein
Low-density-lipoprotein
Heterozygous-familial-hypercholesterolemia
Change-genes
Bad-cholesterol
Crispr-cas9
Pcsk9
Vldl-cholesterol
Hdl-cholesterol
Gene-editing
Heart-attack

How to Select Between Available LDL-C Lowering Therapies

Cardiologists discuss how to select the right treatment for your patient with hyperlipidemia

Nonstatins
Ldl-c
Contra-indications
Tools
Risk
Event
Combination-therapy
Pcsk9
Guidelines
Inclisiran
Sirna

Matching the Intensity of Treatment to Cardiovascular Risk

Dr. Taub discusses how to match the intensity of lipid lowering therapy to the assessed cardiovascular risk.

Risk
Ldlc
Threshold
Pcsk9

New PCSK9 Inhibitor Allows 3-Month Treatment Intervals

"It s a new antibody that has a long half-life so each treatment can be prolonged."

Philadelphia
Pennsylvania
United-states
Australia
Monash
South-australia
American
Eli-lilly
Stephen-nicholls
Victorian-heart-institute
Capital-medical-university
American-heart-association

vimarsana © 2020. All Rights Reserved.